The QualityStocks Daily Stock List
- Apple Rush Company, Inc. (APRU)
- BioCardia, Inc. (BCDA)
- Fission Uranium Corp. (FCUUF)
- HempAmericana, Inc (HMPQ)
- Interlink Electronics, Inc. (LINK)
- Sono-Tek Corporation (SOTK)
- The Movie Studio, Inc. (MVES)
- Protagenic Therapeutics, Inc. (PTIX)
- NXT Energy Solutions, Inc. (NSFDF)
- The Pulse Beverage Corporation (PLSB)
- Guided Therapeutics, Inc. (GTHP)
- Adama Technologies Corporation (ADAC)
- Wizard World, Inc. (WIZD)
- Enertopia Corp. (ENRT)
Apple Rush Company, Inc. (APRU)
Wall Street Analyzer, Penny Stock Base, TipRanks, Market Wire News, Stockwatch, Wallet Investor, Stockhouse, Morningstar, Investing.com, MarketPlace.org, Financial Buzz, MarketWatch, InvestorsHub, Investors Hangout, and GlobeNewswire reported previously on Apple Rush Company, Inc. (APRU), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Apple Rush Company, Inc., via its subsidiary APRU, LLC, is a distributor of CPG (Consumer Packaged Goods )products under the trademarked Apple Rush brand and other labels. The Apple Rush brand has over four decades of existence in the natural beverage industry. The Company develops, bottles, markets, distributes, and sells varied beverages and snacks to wholesale and retail clients in the U.S. Established in 1998, Apple Rush Company lists on the OTC Markets.
The Company offers organic sparkling juice blended beverages, with apple juice as the base under the brand name Apple Rush. The Company is an historical leader in the organic and natural beverage sector. Its aim is to also become the leader in the distribution of anhydrous hemp oil products nationwide.
Subsidiary APRU, LLC concentrates on the development and sales of all natural Apple Rush sparkling juices, and research and development (R&D) of premium hemp extracts, which contain a wide spectrum of cannabinoids and natural hemp derivatives and other active ingredients including the Company’s exclusive agathos active, kratom, kava, blue lotus, and ginseng.
Recently, The Apple Rush Company announced that its proprietary all natural CBD emulsion has been put into the production of Lickinghole Creek’s One Lion 16 ounce sparkling water. Mr. Tony Torgerud, Apple Rush Company Chief Executive Officer, said, “We are excited that our partnership with Lickinghole Creek Brewery to produce this sparkling beverage was aided by David Derian of Botanaway. We have worked on the formulation for our all-natural CBD emulsion for several months and have been chosen as the supplier by Lickinghole Creek’s One Lion.”
Lickinghole Creek Craft Brewery is a farm brewery growing hemp, hops, and barley. It brews world class beer on 300 acres in the heart of the State of Virginia. Lickinghole creek is a water-conscious brewery. The company brews with well water drawn from the deep. Its watershed is purified on site and returned clean to the Lickinghole watershed. The above-mentioned Botanaway, Inc., distributes herbal supplements and beverages to more than 25,000 retail locations in Europe and North America.
Apple Rush Company, Inc. (APRU), closed Thursday's trading session at $0.0122, up 0.826446%, on 429,600 volume with 18 trades. The average volume for the last 3 months is 1,241,731 and the stock's 52-week low/high is $0.004699999/$0.0248.
BioCardia, Inc. (BCDA)
Zacks, Morningstar, StockTwits, Stockwatch, Insider Tracking, Street Insider, Stockopedia, Stockhouse, MarketBeat, Capital Cube, Wallet Investor, AI Stock Finder, Dividend Investor, Barchart, GuruFocus, and Proactive Investors reported previously on BioCardia, Inc. (BCDA), and we also report on the Company, here at the QualityStocks Daily Newsletter.
BioCardia, Inc. is a leader in the development of comprehensive solutions for cardiovascular regenerative therapies. Its biotherapeutic product candidates in clinical development are CardiAMP and CardiALLO cell therapies. In addition, BioCardia partners with other biotherapeutic companies. This is to provide its Helix systems and clinical support to their programs studying therapies for the treatment of heart failure, chronic myocardial ischemia, and acute myocardial infarction. A clinical-stage regenerative medicine company, BioCardia has its corporate office in San Carlos, California. The Company’s shares trade on the NasdaqCM.
BioCardia also offers the Helix biotherapeutic delivery system; and the Morph vascular access product line, which provides catheter products. The Company’s lead therapeutic candidate is the investigational CardiAMP™ Cell Therapy System. This System provides an autologous bone marrow derived cell therapy (using a patient's own cells) for the treatment of two clinical indications. These are heart failure that develops after a heart attack and chronic myocardial ischemia.
BioCardia’s second therapeutic candidate is the investigational CardiALLO™ Cell Therapy System. This is an allogeneic culture expanded "off the shelf" cell therapy derived from donor bone marrow cells that have been identified to meet specified criteria. The therapy has the potential to be advanced for numerous clinical indications, including heart failure.
This past May, BioCardia announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the AVANCE™ steerable introducer product family, designed for introducing different cardiovascular catheters into the heart. This includes through the left side of the heart via the interatrial septum.
The AVANCE steerable introducer family takes advantage of Morph “DNA” technology. This is an enhancement of BioCardia’s FDA-cleared Morph steerable introducer that adds several features that make the devices ideal for use in transseptal procedures and are designed to improve upon commercially-available offerings.
This week, BioCardia announced the U.S. commercial availability of its AVANCE™ Bi-Directional Steerable Introducer Sheath for introducing different cardiovascular catheters into the heart. The product became available in late September. The design of the AVANCE catheter is to have uniform bending characteristics in all directions by having the two tendon wires wrap helically around the catheter shaft, like the double helix in DNA. The uniform bending characteristics, where critically important, are intended to lessen what EPs and ICs refer to as “whip” in catheter navigation, where the catheter jumps to a new location in an uncontrolled fashion.
Yesterday, BioCardia announced the appointment of experienced Chief Executive Officers (CEOs) Mr. Jim Allen and Mr. Andrew Blank to its Board of Directors, effective October 1, 2019. Mr. Allen is CEO and President of Sea Star, Inc., a real estate development company. Mr. Blank is President of National Brands, Inc., an investment group, which was the largest Anheuser-Busch beer distributor in the world before divestiture of those operations.
BioCardia, Inc. (BCDA), closed Thursday's trading session at $3.40, off by 4.2254%, on 11,115 volume with 54 trades. The average volume for the last 3 months is 27,690 and the stock's 52-week low/high is $3.15000009/$17.50.
Fission Uranium Corp. (FCUUF)
Metals News, Zacks, Resource Stock Digest, TipRanks, Wealth Daily, Stock News Now, Junior Mining Network, Energy and Capital, Streetwise Reports, Wallet Investor, Resource World, and Stockhouse reported beforehand on Fission Uranium Corp. (FCUUF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
OTCQX-listed, Fission Uranium Corp. engages in the exploration and development of uranium properties. It owns the award-winning PLS (Patterson Lake South) uranium project, host to the near-surface, high-grade Triple R deposit - part of the largest mineralized trend in the Athabasca Basin region. Significant new high-grade zones have been discovered each year since discovery in 2012. Recently, exploration drilling encountered mineralization 600m west of the trend. Fission Uranium has its head office in Kelowna, British Columbia.
The Company is centering on continued exploration at the large and highly-prospective PLS project and further development of the Triple R deposit. Patterson Lake South (PLS) is host to the above-mentioned Triple R deposit - the most significant high grade shallow depth deposit in the region.
The Triple R deposit is open in manifold directions, especially westwards, towards the high-grade boulder field. A Preliminary Economic Study (PEA) conducted in 2015 shows the Triple R has the potential for an OPEX of $14.02/lb. This would make it one of the world's lowest cost uranium producers.
Fission Uranium has 100 percent ownership of the PLS Property. The Property comprises 17 mineral claims totaling 31,039 ha positioned on the southwest margin of the Athabasca Basin. The property is accessible by all-weather Highway 955 that continues north through the area of the UEX-AREVA Shea Creek deposits to the past producing Cluff Lake uranium mine.
Fission Uranium announced this past May that it filed a technical report on the Triple R Deposit at its PLS project, pursuant to National Instrument 43-101 "Standards of Disclosure for Mineral Projects" (NI 43-101). The Report summarizes the Pre-Feasibility Study (PFS) that highlights the robust economics and long-term potential of the Triple R deposit.
Mineral Reserves were estimated for the Project, based on a hybrid (underground plus open pit) approach to production at PLS. Moreover, the Report recognizes the potential for an underground-only approach that was completed to PEA level and shows major advantages. This includes lower CAPEX (capital expenditure) and shorter construction time. As a result, Fission Uranium is advancing this scenario to Prefeasibility Study stage.
Recently, Fission Uranium announced the results of a Prefeasibility Study for an underground-only mining scenario, conducted by Roscoe Postle Associates Inc. "RPA", and entitled "Pre-Feasibility Study on the Patterson Lake South Property Using Underground Mining Methods" (the U/G PFS) for its' PLS property. The U/G PFS follows the results of a previous PFS report outlining a hybrid mine approach using open pit and underground techniques (the Hybrid PFS).
The U/G PFS highlights a major reduction in CAPEX and time requirements for construction of the Triple R mine because of simplified water control measures for underground mining. With the U/G PFS, access to the deposit is envisioned by way of a decline from land. The revised mining method eliminates the requirement for a system of dykes and slurry walls, dewatering and overburden removal. It results in a reduction of 90 percent of total mine-related earth movement from the Hybrid PFS to the U/G PFS. The reduced earth movement results in decreased surface piles and overall minimized surface footprint.
Fission Uranium Corp. (FCUUF), closed Thursday's trading session at $0.2674, up 6.069%, on 114,178 volume with 34 trades. The average volume for the last 3 months is 214,829 and the stock's 52-week low/high is $0.2386/$0.584699988.
HempAmericana, Inc. (HMPQ)
Beat Penny Stocks, MicroSmallCap, GlobeNewswire, Stock of the Week, Investing.com, Simply Wall St, Epic Stock Picks, The Wolf of Penny Stocks, TMXmoney, Stockwatch, InvestorsHub, and Stockhouse reported beforehand on HempAmericana, Inc. (HMPQ), and today we report on the Company, here at the QualityStocks Daily Newsletter.
HempAmericana, Inc. researches, develops, and sells products made of industrial hemp in the United States. The Company is an emerging participant in the CBD (cannabidiol) products market. It owns and operates a high-capacity, state-of-the-art CBD extraction and processing facility in Augusta, Maine. HempAmericana is based in New York, New York. The Company lists on the OTC Markets.
HempAmericana’s extraction and processing facility has a supersized supercritical CO2 extraction system, centrifugal partition chromatography refinement technology, and a mechanized fully-automated CBD bottling system. Additionally, the Company researches, develops, and sells products made of industrial hemp. This includes a popular brand of hemp rolling papers marketed under the brand name, “Rolling Thunders”.
HempAmericana’s CBD oil business uses the brand designation, “Weed Got Oil”. HempAmericana continues to pursue an active place in the CBD white label market segment, chiefly for those companies seeking premium full-spectrum distillate CBD oil.
HempAmericana has purchased a 100-liter solvent recovery system, the Ecochyll X7 High Speed Evaporator. This system represents a 400 percent increase in evaporative capacity for the Company’s production line technology.
HempAmericana’s Management notes that chemical solvents (including butane, hexane, ethanol, propane, and isopropyl alcohol, all used in cannabis extraction processes) can be prohibitively costly, making solvent cost a major factor determining long-term viability in the CBD production space. Management noted that HempAmericana’s investment in a top-tier high-capacity solvent recovery system should pay for itself in the near term and then positively impact the Company’s margins for years to come.
In August, HempAmericana announced the launch of its North American CBD Product Sales Force. This move comes on the heels of a significant production and bottling run that ramped in-house inventories of premium-quality CBD products to record levels. The Company has experienced a considerable expansion in its distribution footprint, with distributors in Florida, Nevada, Utah, California, Maine, Tennessee, Kentucky, Mexico, and Costa Rica.
HempAmericana, Inc. (HMPQ), closed Thursday's trading session at $0.0054, up 1.8868%, on 12,109,858 volume with 189 trades. The average volume for the last 3 months is 6,806,782 and the stock's 52-week low/high is $0.0046/$0.027699999.
Interlink Electronics, Inc. (LINK)
MacroTrends, GlobeNewswire, Street Insider, AI Stock Finder, Stockhouse, Last10k, Simply Wall St, TMXmoney, Investing.com, MarketBeat, Stockopedia, InvestorsHub, and Market Screener reported earlier on Interlink Electronics, Inc. (LINK), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Interlink Electronics, Inc. is a world-leading trusted advisor and technology partner in the advancing world of human-machine interface (HMI) and force-sensing technologies. It has led the printed electronics industry in its commercialization of its patented Force-Sensing Resistor (FSR®) technology that has enabled strong and reliable HMI solutions. Formed in 1985, Interlink Electronics is headquartered in Westlake Village, California. The Company lists on the OTC Markets.
Interlink Electronics’ products include Force Sensing Resistor® technology, Force sensing linear potentiometers (FSLP), and integrated mouse modules & pointing solutions. The Company was founded on the invention and commercialization of the Force Sensing Resistor®. As Interlink transitions from an FSR® sensor supplier to an HMI solution provider, it is pursuing and embracing leading-edge sensor technology platforms. Interlink is working to advance the HMI and Force-Sensing Technology Revolution™.
Additionally, Interlink Electronics serves its customer base from its global research and development (R&D) center in Singapore, its printed-electronics manufacturing facility in Shenzhen, China, and its global distribution and logistics center in Hong Kong. Furthermore, the Company maintains technical and sales offices in Japan and at different locations in the United States.
Interlink delivers multi-platform sensor solutions to the world's major OEMs (Original Equipment Manufacturers), Tiers and Integrators. The Company’s solutions focus on handheld user input, menu navigation, cursor control, and other intuitive interface technologies for the world's top electronics manufacturers.
Interlink has a proven record of accomplishment of supplying HMI solutions for mission-critical applications in a wide array of markets. These include, but are not limited to, consumer electronics, automotive, industrial, and medical devices. The Company’s strategy is built on the identification and qualification of inventive HMI technologies, and using them intelligently to deliver high value-added solutions to its customers. Its product development teams skilled capabilities are in concept definition, rapid prototyping, hardware and firmware development and integration support.
Today, Interlink Electronics announced that it is considering a listing of its common shares on a United States or foreign stock exchange during 2020. Interlink voluntarily delisted its common stock from the Nasdaq Stock Market in Q1 of 2019. The Company’s shares are presently quoted on the Pink tier of OTC Markets Group.
Mr. Steven N. Bronson, Chief Executive Officer of Interlink Electronics, said, "In light of our strategy to actively pursue acquisitions in 2020 and beyond, Interlink's management felt that the benefits of increased visibility and access to the capital markets outweighed the cost savings of not being listed."
Interlink Electronics, Inc. (LINK), closed Thursday's trading session at $3.52, off by 4.607%, on 5,417 volume with 19 trades. The average volume for the last 3 months is 10,528 and the stock's 52-week low/high is $1.62/$8.60000038.
Sono-Tek Corporation (SOTK)
Zacks, Micro Small Cap, Capital Cube, Street Insider, MarketBeat, Silicon Investor, Simply Wall St, Stockwatch, Whale Wisdom, InvestorsHub, Information Vine, OTC Markets, and Wallet Investor reported earlier on Sono-Tek Corporation (SOTK), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Sono-Tek Corporation designs and manufactures ultrasonic coating systems for applying on parts and components for the microelectronics/electronics, alternative energy, medical, industrial, and research and development/other markets worldwide. It is the leading developer and manufacturer of ultrasonic coating systems. The Company’s solutions are environmentally-friendly, efficient, and highly reliable. OTCQX-listed, Sono-Tek is headquartered in Milton, New York.
Ultrasonic coating is an inventive, environmentally-friendly, low velocity spray technology. It creates micron thickness, very uniform protective and functional thin films with no clogging and very little overspray.
Sono-Tek develops and manufactures ultrasonic coating systems for applying precise, thin film coatings to protect, strengthen or smooth surfaces on parts and components for varied markets. These include specialized glass applications in construction and automotive. The Company’s solutions enable substantial reductions in overspray, savings in raw material, water and energy usage. In addition, they provide improved process repeatability, transfer efficiency, high uniformity and reduced emissions.
Sono-Tek’s unique, patented coating systems provide total solutions to complex and varied coating challenges in an array of global industries, from research and development (R&D) through high volume production. All of its ultrasonic coating systems integrate Sono-Tek ultrasonic nozzles, liquid delivery, and full system controls. Machines range from R&D tabletop systems, standalone fully enclosed programmable systems, and also wide area continuous production inline systems.
Recently, Sono-Tek announced a business development project to expand its Milton, New York facilities with participation and financial incentives from Empire State Development (ESD) and Central Hudson Gas & Electric grants. The proposed expansion planned by the Company will comprise renovations to change existing warehouse/office space over to high-technology manufacturing facilities. As part of this expansion, a number of pieces of manufacturing equipment will be purchased, including a precision laser welder, advanced Mill/CNC machinery, and additional equipment to support a new 6-axis robotics product line.
Last month, Sono-Tek announced that it entered into an agreement with Avior Bio Incorporated for Sono-Tek ultrasonic coating equipment to be used in the Avior product development and future manufacturing process. Avior Bio obtained Sono-Tek's medical device coating machine that will be paid for through a combination of cash and Avior Bio equity. Avior Bio (Durham, North Carolina) is a clinical stage, pharmaceutical company developing drugs for distressed neurological conditions.
Sono-Tek Corporation (SOTK), closed Thursday's trading session at $2.94, up 3.8869%, on 13,300 volume with 26 trades. The average volume for the last 3 months is 3,143 and the stock's 52-week low/high is $1.89999997/$3.0999999.
The Movie Studio, Inc. (MVES)
Infront Analytics, Insider Financial, Investing.com, Morningstar, Simply Wall St, Stockopedia, Emerging Growth, Nasdaq, Global Banking and Finance, Market Screener, Wallet Investor, TradingView, Stockhouse, InvestorsHub, and GlobeNewswire reported earlier on The Movie Studio, Inc. (MVES), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
The Movie Studio, Inc. is a digitally disruptive vertically integrated motion picture production and distribution company. It concentrates on the independent motion picture sector with completed motion picture and production assets. The Company is changing traditional media content delivery systems with its digital business model of motion picture distribution. Its intends direct server access of its content with geo fractured territories for global distribution.
The Movie Studio has its corporate headquarters in Fort Lauderdale, Florida. The Company previously went by the name Destination Television, Inc. It changed its name to The Movie Studio, Inc. in November of 2012. Established in 1961, the Company lists on the OTC Markets.
The Movie Studio acquires, develops, manufactures, and distributes independent motion picture content for international consumption in Theatrical, Video on Demand (VOD), Foreign Sales and on diverse media devices. The Company has a strategic partnership and joint venture (JV) with Wonderfilm Media Corporation. This is for the asset alignment, co-production, as well as acquisition of two intellectual properties (IPs).
Last month, The Movie Studio announced that it successfully launched its brand new app that is part of its Over The Top (OTT) platform, on the Google Play Store and Apple App Store. This application is now live. It can be found and downloaded for free by searching for The Movie Studio on either app store. The Company’s intention is to add new content by purchasing film libraries, along with strategic partnership, license and revenue sharing aggregation for other motion picture content looking to participate on its platform under The Movie Studio brand.
Yesterday, The Movie Studio announced that its Chief Executive Officer (CEO) is scheduled to present at the 147th National Investment Banking Association (NIBA) conference scheduled for November 12-13, 2019 at the Westin Times Square Hotel in New York, New York.
Mr. Gordon Scott Venters, CEO and President of The Movie Studio, stated, "We are honored to present at the celebrated NIBA conference in Time Square New York on November 13th. We are excited to present our unique business model with the sizable audience of investors, broker dealers as well as other financial professionals that recognize the tremendous shift that is taking place in our sector."
The Movie Studio, Inc. (MVES), closed Thursday's trading session at $0.03, off by 6.1033%, on 11,000 volume with 2 trades. The average volume for the last 3 months is 17,780 and the stock's 52-week low/high is $0.009999999/$0.150000005.
Protagenic Therapeutics, Inc. (PTIX)
InvestorsHub, Zacks, last10k, Market Screener, Stockopedia, Barchart, YCharts, GuruFocus, MarketWatch, Infront Analytics, OTC Markets, Investor Point, Market Exclusive, Simply Wall St, Annual Reports, Wallet Investor, Marketbeat, Morningstar, Stockhouse, 4-Traders, and Capital Cube reported earlier on Protagenic Therapeutics, Inc. (PTIX), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Protagenic Therapeutics, Inc. is a pre-clinical biopharmaceutical company listed on the OTC Markets’ OTCQB. The Company consists of a team of scientists and biotechnology industry veterans centered on realizing the potential of one of nature’s most highly-conserved neuropeptides. It works to develop first-in-class neuro-active peptides into human therapeutics to treat anxiety, treatment-resistant depression, addiction, as well as other disorders. Protagenic Therapeutics has its corporate office in New York, New York. Protagenic Therapeutics Canada, Inc. has its office in Stouffville, Ontario.
Protagenic Therapeutics’ mission is to provide inventive, safe and effective treatments for anxiety and depression through using neuropeptide hormones to restore normal emotionality. The Company is developing PT00114 as a therapeutic for anxiety, depression, post-traumatic stress disorder (PTSD), and addiction.
Protagenic’s emphasis is novel anti-anxiety and anti-depression natural brain hormone pharmaceutical agents, based on encouraging preclinical results. The Company has created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
Protagenic Therapeutics previously announced that the naturally-occurring brain peptide upon which its lead drug compound, PT00114, is based, known scientifically as teneurin C-terminal associated peptide (TCAP), was featured in three peer-reviewed publications in major scientific journals. The three high profile publications support the potential of Protagenic’s Synthetic TCAP to treat stress-related psychological disorders. TCAP-1 has shown encouraging results in pre-clinical neurologic testing in anxiety and depression.
Pertaining to its PT00114, the Company’s studies have shown evidence that PT00114 is a strong regulator of cellular metabolism. This includes neuronal cells. Protagenic believes that because this mechanism is similar across different animal species and humans, that its experimental observations can form the basis for its molecule to work by significantly improving neuronal health.
Protagenic Therapeutics states that TCAP-1 is a promising treatment for anxiety and depression as it appears to alleviate high stress response-related behaviors. The Company’s current work aims to actively pursue therapies that harness the stress-diminishing capabilities of TCAP-1 in order to increase stress-response.
Taking advantage of activity influencing numerous neuropathological processes, Protagenic Therapeutics is reaching beyond the boundaries of traditional therapeutics for stress-related disorders, through concentrating on restoring the body’s natural equilibrium.
Protagenic Therapeutics, Inc. (PTIX), closed Thursday's trading session at $2.00, up 42.8571%, on 101 volume with 2 trades. The average volume for the last 3 months is 1 and the stock's 52-week low/high is $1.39999997/$2.29999995.
NXT Energy Solutions, Inc. (NSFDF)
Serious Traders, SmarTrend Newsletters, Vantage Wire, StockOoodles, and Streetwise Reports reported previously on NXT Energy Solutions, Inc. (NSFDF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
NXT Energy Solutions, Inc. is a technology business. The Company’s proprietary Stress Field Detection (SFD®) survey system uses quantum-scale sensors to detect gravity field perturbations in an airborne survey method that can be used onshore and offshore to remotely identify areas with exploration potential for traps and reservoirs. Established in 1994, NXT Energy Solutions is headquartered in Calgary, Alberta.
The Company’s unique geophysical service is for the upstream oil & gas industry. SFD® is environmentally friendly. It is unaffected by ground security issues or difficult terrain. SFD® is an airborne tool. It provides information on areas favorable to fluid entrapment in the sedimentary column. The SFD® survey is complementary to existing geophysical methods, especially seismic programs.
NXT Energy Solutions provides its clients with an effective and reliable method to lessen time, costs, and risks related to exploration. The SFD® survey system allows its clients to focus their hydrocarbon exploration decisions concerning land commitments, data acquisition expenditures, and prospect prioritization on areas with the greatest potential.
SFD®, in pre-seismic applications, can produce high-potential prospect leads in large underexplored regions. In post-seismic applications, SFD® can prioritize seismic prospects based on their reservoir potentials.
In January 2018, NXT Energy Solutions announced the first worldwide patent of the Stress Field Detection (SFD®) Technology and the development of a new generation of sensors, which will enhance the Company’s ability to provide higher quality survey results. NXT is negotiating commercial contracts for the application of its proprietary SFD® oil & gas exploration method with governments, national oil companies, and other industry participants.
Recently, NXT Energy Solutions announced its financial and operating results for the quarter-ended June 30, 2018. No survey Revenues were recorded for the first two quarters of 2018. A Net Loss of $1.96 million was recorded for the three months ended June 30, 2018. A Net Loss of $3.92 million was recorded for the six months ended June 30, 2018.
NXT Energy Solutions, Inc. (NSFDF), closed Thursday's trading session at $0.31, up 25.2019%, on 5,000 volume with 3 trades. The average volume for the last 3 months is 12,692 and the stock's 52-week low/high is $0.150000005/$0.689999997.
The Pulse Beverage Corporation (PLSB)
The Green Baron, Greenbackers, Microcap MarketPlace, Wall St Insider Stocks, Ceocast News, SmallCap Network, FreeRealTime, PennyStocksV2, BestStocksDaily, Wall Street Resources, RedChip, Marketbeat.com, HoleinOneStocks.net, and PennyStockClub reported previously on The Pulse Beverage Corporation (PLSB), and today we report on the Company, here at the QualityStocks Daily Newsletter.
The Pulse Beverage Corporation is the maker of Natural Cabana® Lemonades, Limeades, and Coconut Waters. It introduced Natural Cabana® Lemonade in 2012. Since that time, it has developed a multi-national distribution system through more than 155 distributors in 49 U.S. States, Canada, Mexico, Panama, Bermuda, and Ireland. OTCQB-listed, The Pulse Beverage Corporation is headquarterered in Northglenn, Colorado.
The Company’s aim is to be one of the market leaders in the development and marketing of nutritional/functional beverage products, which provide real health benefits to a large portion of the population and are convenient and appealing to consumers.
Pulse Beverage’s business model uses warehouse direct and key accounts. The Company has secured greater than 20,000 listings for its Lemonades and Limeades and over 5,000 listings for its Coconut Waters with regional and national grocery and convenience chain stores.
The Company offers Natural Cabana® Lemonade/Limeade in seven, low-calorie flavors. Additionally, Pulse offers Natural Cabana® Coconut Water in pineapple and natural flavors.
Pulse Beverage teams up with major retailers. These retailers include Walmart, Albertsons/Safeway, Food Max, Kroger, Stater Bros, Houchens, 7-Eleven, United C-stores, Kmart, and Weis Markets. Major retailers also include King Kullen, WinCo Foods, Price Less Markets, Hy-Vee Supermarket, Gristede's Foods, Toot n Totem, and Travel America.
Recently, Pulse Beverage announced that it acquired international distribution for its Natural Cabana® Coconut Waters in the People’s Republic of China (PRC) via its new U.S. based distribution partner, Better4U Food & Beverage, Inc.
Better4U has distribution in the PRC and consumer demand for more than 15,000 cases per month worth a minimum of $450K per quarter in Net Revenues for Pulse. In this partnership, Better4U pays for the product up front. This eliminates the credit risks for Pulse.
Furthermore, in March, Pulse announced that it acquired international distribution for its Natural Cabana® Lemonades & Limeades in the Republic of China (Taiwan) via Better4U Food & Beverage. Better4U has distribution in Taiwan and consumer demand for more than 6,500 cases per month worth a minimum of $200K per quarter in additional Net Revenues for Pulse.
The Pulse Beverage Corporation (PLSB), closed Thursday's trading session at $0.0001, even for the day, on 1,006,525 volume with 3 trades. The average volume for the last 3 months is 5,376,377 and the stock's 52-week low/high is $0.000000999/$0.001099999.
Guided Therapeutics, Inc. (GTHP)
NYC Marketing Inc., DSR News, PHUB News, TheNextBigTrade, PennyStocks24, TopPennyStockMovers, SmallCapVoice, PennyTrader Publisher, Pennystocktweeters.com, Stock Beast, OTCStars.com, BestDamnPennyStocks, PennyStockLocks.com, ResearchOTC, Stock Commander, StockRockandRoll, AllPennyStocks, and Momentum Trades reported on Guided Therapeutics, Inc. (GTHP), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTC Bulletin Board, Guided Therapeutics, Inc. is the creator of a fast and painless testing platform. This platform is for the early detection of disease founded on the Company's patented biophotonic technology that uses light to detect disease at the cellular level. The Company’s initial product is the LuViva® Advanced Cervical Scan. This is a non-invasive device used to detect cervical disease rapidly and at the point of care. Guided Therapeutics has its corporate office in Norcross, Georgia.
The LuViva® Advanced Cervical Scan is an investigational device. It is limited by federal law to investigational use in the United States. The design of LuViva® is as a fast, painless test that, unlike Pap smears and HPV testing, does not necessitate a tissue sample or the delay of laboratory analysis.
LuViva® scans the cervix with light. It utilizes spectroscopy to measure how light interacts with the cervical tissue. Spectroscopy identifies chemical and structural indicators of pre-cancer, which may be below the surface of the cervix or misdiagnosed as benign.
This technique is called biophotonics. Biophotonics is the science of generating and harnessing light to image, detect, as well as manipulate biological materials.
The LuViva® Advanced Cervical Scan technology (in a multi-center clinical trial, with women at risk for cervical disease) was able to detect cervical cancer up to two years earlier than conventional modalities, according to published reports. The device is used in combination with the LuViva® Cervical Guide single-use patient interface and calibration disposable.
The LuViva® Advanced Cervical Scan is under U.S. Food and Drug Administration (FDA) Premarket review. Guided Therapeutics is also developing a non-invasive test for the early detection of esophageal cancer utilizing this technology platform.
Recently, Guided Therapeutics reported record sales for a quarter in Indonesia; eight LuViva® Advanced Cervical Scans were shipped in Q4 of last year. Furthermore, Indonesia ordered 4,500 single-use Cervical Guides that were shipped along with the LuViva devices.
This increase in orders of high-margin Cervical Guides indicates that installed LuViva units are starting to see more usage in hospitals and clinics. Founded on prior studies and evaluations of LuViva, medical researchers in Indonesia are recommending the LuViva test as an alternative to the Pap test for cervical cancer screening.
In addition, Guided Therapeutics recently reported that it received Regulatory Approval from the Indian Ministry of Health & Family Welfare to permit commercialization of the LuViva device and disposables. The Ministry concluded that the LuViva device is “Non Invasive” and therefore is “not regulated under the Drugs and Cosmetics Act 1940 and Medical Device Rules 2017 thereunder.” Consequently, LuViva can now be commercialized in India.
Guided Therapeutics, Inc. (GTHP), closed Thursday's trading session at $0.20975, up 31.0938%, on 3,257 volume with 9 trades. The average volume for the last 3 months is 7,757 and the stock's 52-week low/high is $0.0206/$3.03999996.
Adama Technologies Corporation (ADAC)
StreetInsider, InvestorsHub, OTC Markets, Morningstar, and Stockhouse reported on Adama Technologies Corporation (ADAC), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Adama Technologies Corporation is a Venture Capital Company listed on the OTCQB. It owns, operates, and invests in technology companies and also startups and expansion companies. The Company has a hands-on approach and works to develop the management and leaders around the corporate landscape to transform big ideas into game changing execution in the field. Adama Technologies has its corporate office in Henderson, Nevada.
Adama Technologies has exceptional access to equity lines of credit, equity funds, private investors, incubators, mentor partners and close ties with Fortune 100, 500 and 1000 companies who serve as exit strategies for many of Adama’s investments.
Adama Technologies’ portfolio companies include Alpine Industries and SafeGuard Pii. Its flagship investment is Alpine Industries located in Utah. Alpine specializes in machining and aerospace manufacturing.
This investment and acquisition launches Adama Technologies into the fast expanding field of aerospace technology. Furthermore, it positions Adama with the stability of being a defense contractor for the U.S. military.
Since its establishment in 1974, Alpine Industries has manufactured several hundred aerospace landing gear components and other spare parts. It continues to work as a US government contractor.
Presently, Alpine holds more than 15 US Military contracts. Most of these contracts are with the US Air Force. Alpine Industries also manufactures parts for a number of private companies. These include parts for drilling components utilized in oil and water wells, roller-coasters, motorcycles, zip line parts, crash pads, as well as drilling carts.
SafeGuard Pii is an industry pioneer and top-tier Privacy Management Firm. It provides compliance solutions to companies across the United States. In addition, SafeGuard Pii is the provider of a strong identity theft protection and restoration product.
The Company’s PII Defender program monitors internet black market sites, other internet trading sites where ID thieves buy and sell information, utility and phone records, public databases, criminal databases and DMV records, plus credit files for one’s personal information.
Recently, Adama Technologies announced that it was accepted and successfully up-listed to the OTCQB marketplace with OTC Markets. Adama had outlined a course towards growth and development. This path included development of additional revenue streams, growing revenues within their present operations, and up-listing into the QB Marketplace.
In addition, Adama Technologies also recently announced that the Company will bid on an additional $3,000,000 in new government contracts with at least $2,000,000 of that number being for US Military Defense contracts. Adama detailed its month-of-March bidding plan and strategy and its optimism concerning its ability to win these contracts. As the bidding process is underway, Adama Technologies will continue to look for additional revenue opportunities in its commercial and retail outlets.
Adama Technologies Corporation (ADAC), closed Thursday's trading session at $0.0005, up 400.00%, on 50,000 volume with 2 trades. The average volume for the last 3 months is 74,095 and the stock's 52-week low/high is $0.009999999/$0.180000007.
Wizard World, Inc. (WIZD)
Wall Street Resources and TopPennyStockMovers reported earlier on Wizard World, Inc. (WIZD), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Wizard World, Inc. is the foremost provider of multiple Comic Cons and pop culture conventions around the world. The Company produces Comic Cons (live multimedia conventions) and pop culture conventions. These celebrate pop-fi, pop culture, movies, television, cosplay, comics, graphic novels, toys, video gaming, sci-fi, gaming, original art, collectibles, contests and more. Wizard World has its headquarters in El Segundo, California. The Company’s shares trade on the OTC Bulletin Board (OTC BB).
Wizard World’s events frequently feature celebrities from movies and TV, artists and writers, and events such as premieres, gaming tournaments, panels, as well as costume contests. The Company has its ComicConBox™. This is a subscription-based premium monthly box service. It provides fans the opportunity to receive exclusive collectibles, toys, technology, games, licensed artwork, comics, apparel, Wizard World Comic Con tickets, VIP discounts and more, delivered to their doors.
The Company’s Comic Cons provide sales, marketing, promotions, public relations, advertising, and sponsorship opportunities for entertainment companies, toy companies, gaming companies, publishing companies, marketers, corporate sponsors, and retailers.
Wizard World Digital is the Company’s online publication. It covers new and upcoming products and talents in the pop culture world. Also, Wizard World has established a new SocialCon™ Operating Unit within Wizard World. SocialCon™ will produce a series of conventions. These will feature meet-and-greets, live performances, Q&A panels, autographs, photo opportunities and more with many of today’s most-followed social media influencers.
In addition, Wizard World has its CONtv. This is a subscription-based digital service. It brings fans their favorite films, TV series, comics, behind the scenes access to Wizard World Comic Cons, and more.
CONtv provides consumers access to thousands of hours of exclusive content highlighting an original slate of programming and a comprehensive digital catalog of over 1,200 titles. Furthermore, Wizard World has launched the new music concert series, and the Wizard World Store.
In September 2017, Wizard World announced its partnership with CNLive to distribute streamed content in the People's Republic of China (PRC). This partnership with CNLive, one of only seven entities licensed to distribute content over the internet in the PRC, provides Wizard World China, a wholly-owned subsidiary of Wizard World, a multi-year right and license to program a 24/7, advertising supported channel throughout all of mainland China. This includes Macao and Hong Kong.
Wizard World, Inc. (WIZD), closed Thursday's trading session at $0.13, up 28.5856%, on 870 volume with 2 trades. The average volume for the last 3 months is 41,225 and the stock's 52-week low/high is $0.05/$0.217999994.
Enertopia Corp. (ENRT)
Penny Stock General, Shiznit Stocks, Cannabis Financial Network News, PennyStocks24, Fast Money Alerts, Stock Shock and Awe, Penny Champions, Equities.com, MassiveStockProfits, Wall Street Equities Research, Stockgoodies, GrowthPennyStocks, and Penny Dreamers reported earlier on Enertopia Corp. (ENRT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Enertopia Corp. is exploring a portfolio of three prospective lithium projects in the State of Nevada. Additionally, at the same time, the Company is working with water purification technology believed to be able to recover Lithium from brine solutions. Enertopia has its corporate office in Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQB.
Enertopia announced in April 2017 the formation of a Lithium business division for the exploration of Lithium. In May 2017, it closed the definitive agreement for the Lithium exploration project in Nevada.
In June 2017, Enertopia announced its Surface Exploration Program in Nevada. In Nevada, the Company has 2,560 acres of placer mining claims staked in Edwards, Smith and Big Smoky valleys.
The Central Nevada Lithium Brine Projects are proximal to an existing lithium mine. There is all weather access on paved roads and it is an ideal evaporation climate.
Genesis Water Technologies (GWT) is a partner of Enertopia. GWT is a manufacturer of advanced, innovative and sustainable treatment solutions for applications in process water, drinking water, water reuse and waste water for the energy, agriculture processing, industrial, municipal infrastructure, and building/hotel sectors.
Since September 2017, GWT has been evaluating data obtained from the first bench test results and other technical data provided by Enertopia to complete a larger and enhanced lithium recovery system. This $200,000 pre-paid second phase bench test is now complete. The second phase of the second bench test will use synthetic brine solutions, which will be created from the surface samples from the two bulk samples taken at Enertopia’s Clayton Valley project.
The next steps for the Company in 2018 are a bench test build out this month and preparation of synthetic brines in February. In March and April, bench testing of synthetic lithium brines will take place. In May will be final laboratory lithium recovery and Li2CO3 grade results.
Enertopia Corp. (ENRT), closed Thursday's trading session at $0.0094, up 44.6154%, on 3,500 volume with 2 trades. The average volume for the last 3 months is 77,957 and the stock's 52-week low/high is $0.0048/$0.035.
The QualityStocks Company Corner
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
- HTC Extraction Systems (TSX.V: HTC)
- CloudCommerce (OTCQB: CLWD)
- ChineseInvestors.com (CIIX)
- Geyser Brands Inc. (TSX.V: GYSR)
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
- Marijuana Company of America (OTCQB: MCOA, MCOAD)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- MustGrow Biologics Corp. (CSE: MGRO)
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
- Spectrum Global Solutions, Inc. (SGSI)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- VPR Brands, LP (VPRB)
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) ("GGB" or "the Company") is pleased to announce that it has opened its 150th Seventh Sense® Botanical Therapy ("Seventh Sense") CBD mall-based shop. The first Seventh Sense® shop opened in early February.
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.
In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.
Products under the Green Growth Brand umbrella include:
- CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
- Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
- Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
- Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
- The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
- XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.
Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.
Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.
Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.
Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.
CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.
CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.
Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.
Green Growth Brands Inc. (OTCQB: GGBXF), closed Thursday's trading session at $1.14, up 17.1393%, on 485,231 volume with 469 trades. The average volume for the last 3 months is 391,896 and the stock's 52-week low/high is $0.843599975/$5.20499992.
- Green Growth Brands Opens 150th CBD Shop and Provides Progress Update
- AI Analytics Report Reveals Drivers of the CBD Craze
- 420 with CNW – Cannabis Expo in West Michigan Set to Educate Consumers and Businesses about the Marijuana Industry
HTC Extraction Systems (TSX.V: HTC)
The proprietary ethanol, solvent and glycol reclamation operations of HTC Extraction Systems (TSX.V: HTC) granted the Saskatchewan, Canada-based company a three-fold increase in revenue during the past year, according to unaudited interim condensed consolidated financial results published August 28 (http://cnw.fm/34WDf).
HTC Extraction Systems (TSX.V: HTC) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.
Advanced Extraction Technologies
For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:
- LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
- PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
- Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.
Delta Purification® Technology
HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:
- Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
- Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
- Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.
Hemp Biomass and Tolling Contracts
HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.
Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.
Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.
The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.
Sales and Offtake Agreements
HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.
HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.
Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.
Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.
HTC Extraction Systems (TSX.V: HTC), closed Thursday's trading session at $0.39, up 1.2987%, on 127,500 volume with 27 trades. The average volume for the last 3 months is 195,960 and the stock's 52-week low/high is $0.079999998/$1.24.
- Solvent-based CO2 Distillation Operation Generates Three-Fold Revenue Hike for HTC Extraction Systems (TSX.V: HTC) Ahead of CBD Strategy
- HTC Extraction Systems (TSX.V: HTC) Achieves Growing Revenues in Q2; Develops CBD FSO Distillate Operation
- USDA Officials Note Challenges in Providing Insurance Coverage to Hemp Farmers
CloudCommerce (OTCQB: CLWD)
CloudCommerce Inc. (OTCQB: CLWD) today announces the broadcast of its exclusive audio interview with NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community. The interview can be heard at http://nnw.fm/V91Jg.
CloudCommerce (OTCQB: CLWD) is a leading provider of audience-driven business intelligence and marketing solutions. Together with its wholly owned subsidiaries, CloudCommerce delivers invaluable end-to-end business intelligence and marketing solutions through a range of services and capabilities.
SWARM is an end-to-end solution that applies advanced data science, behavioral science, artificial intelligence and market research techniques to deliver powerful audience-driven business intelligence that converts opportunities into business success.
Through marketing, brand perception, customer-relationship management, human-resources management and operational logistics applications, CloudCommerce’s SWARM solution helps businesses determine who to talk to, what to say and how to motivate targeted audiences to take meaningful action.
Marketers have largely taken a blanket approach to communication. The same messages are often sent across an entire customer audience with little regard for how different groups of people communicate, build communities and develop their purchasing habits. When marketers do segment audiences, they use objective selection criteria such as income, geography, education or purchase history to deduce attitudes or intentions.
However, research shows that motivations and feelings are much more accurate at predicting behavior. The challenge for businesses is that these factors are also the hardest to gather from audience data. CloudCommerce provides that audience-intelligent data through SWARM, its proprietary behavioral-science approach to audience creation and communication. Through SWARM, CloudCommerce helps marketers identify consumer motivations and triggers in order to effectively predict and influence actions. When companies influence action, they can change opinions, gather support, motivate purchases and inspire change.
In a fast-developing global business intelligence market estimated to grow from $16.3 billion in 2016 to $34.3 billion by 2022, CloudCommerce stands apart as an innovator and true partner, able to deliver data-driven intelligence and solutions that enable its customers to strengthen their brands, deliver their messages and reach their goals.
THE SWARM—Intelligent Audience Building
The core of the CloudCommerce solution – and what separates CloudCommerce from other audience data companies – is the company’s unique approach to audience building. The concept of “personas” has been around for decades, but CloudCommerce takes that concept to the next level. The SWARM was developed to identify not only who to talk to but also what to say in order to motivate target audiences to take meaningful action. Using CloudCommerce’s proprietary clustering and behavioral analysis techniques, businesses can identify target audiences and deliver messages that are more focused and efficient. CloudCommerce not only helps its client partners find the right people to talk to but also identifies the most powerful message to send.
BUZZ—Behavior-Based Market Research
Market research is evolving. Research techniques developed and used today are more sophisticated and backed by strong data science. Despite these changes, many traditional research firms have failed to innovate: small sample sizes, survey design bias, improper weighting and gut-intuition sampling are just some of the issues that plague the market-research industry. Through BUZZ, CloudCommerce has automated the market research process to provide a level of statistical depth beyond what traditional firms can offer. BUZZ offers businesses the ability to put their finger on the pulse of the marketplace in the moment. Using a wide range of internal and external data sources such as customer data, social media activity, and micro and macro trends, BUZZ deduces attitudes, emotions and opinions.
HIVE—Redefined Geographic Targeting
Conventional geographic audience targeting is outdated. Arbitrary units of location such as counties, cities, DMAs and regions were created centuries ago based on land-rights ownership. Their use in understanding people’s behavior, purchase habits and underlying values is minimal. CloudCommerce has found a much more powerful, efficient and effective way of targeting by clustering people into granular geographic tribes called HIVES. HIVES are defined by attributes such as common language (e.g., colloquialisms), shared experience and narratives (e.g., climate, history), and concentrated demography and biology (e.g., ethnicity, age). Based on the needs of its clients, CloudCommerce can completely redraw the geographic lines based on various Hive selection criteria. Using this exclusive HIVE approach, CloudCommerce clients experience more efficient and effective marketing, make more intelligent business decisions and enjoy more growth.
HONEY—Advanced Reporting and Visualization
Advanced-audience, data-analysis technologies are useless if they don’t produce simple, powerful and actionable business intelligence. HONEY comes with user-friendly reporting and visualization tools to organize and explain all of the advance-data science into a simple-to-understand format for decision makers. HONEY combines the intelligence of client CRM data with third-party consumer data and targeted market research to create a powerful foundation for any audience-intelligence solution.
Data Propria delivers the highest Return on Investment (“ROI”) for their customers’ digital marketing campaigns, by utilizing sophisticated data science to identify the correct universes to target relevant audiences. Their ability to understand and translate data drives every decision they make. By listening to and analyzing their customers’ data they are able to make informed decisions that positively impact their customers’ business. Data Propria leverages industry-best tools to aggregate and visualize data across multiple sources, and then their data and behavioral scientists segment and model that data to be deployed in targeted marketing campaigns. They have data analytics expertise in retail, wholesale, distribution, logistics, manufacturing, political, and several other industries.
Parscale Digital helps their customers get their message out, educate their market and tell their story. They do so creatively and effectively by deploying powerful call-to-action digital campaigns with national reach and boosting exposure and validation with coordinated advertising in print media. Parscale Digital’s fully-developed marketing plans are founded on sound research methodologies, brand audits and exploration of the competitive landscape. Whether their customer is a challenger brand, a political candidate, or a well-known household name, Parscale Digital’s strategists are skilled at leveraging data and creating campaigns that move people to make decisions.
Giles Design Bureau
Giles Design Bureau approaches branding from a “big picture” perspective, establishing a strong identity and then building on that to develop a comprehensive branding program that tells the customer’s story, and articulates what sets the customer apart from their competitors and establishes the customer in their market.
WebTegrity develops commerce-focused, user-friendly digital websites and apps that elevate their customer’s marketing position and draw consumers to their products and services. Their platform-agnostic approach allows WebTegrity to architect and build solutions that are the best fit for each customer. Once the digital properties are built, their experts will help manage and protect the website or app and provide the expertise needed to scale the infrastructure needed as the customer’s business grows.
Andrew Van Noy, CEO & Chairman of CloudCommerce Board of Directors
Andrew Van Noy has been a director of CloudCommerce since November 2012, president of the company since April 2012, and the CEO of the company since August 2012. He also served as executive vice president of CloudCommerce from November 2011 to April 2012 and vice president of Sales and Marketing of the company from May 2011 to November 2011. From January 2009 to April 2011, Van Noy served as the vice president of Sales and Marketing for PageTransformer, which provided web and software development for iPad, iPhone and Android devices. Van Noy came to CloudCommerce with experience in digital marketing, private equity and investment banking. During his years at the company, Van Noy led the efforts to rebrand and restructure the business and presided over the acquisition of a number of companies. Van Noy graduated from BYU with a Bachelor of Science degree.
Gregory Boden, CFO and Board of Directors
Gregory Boden became a director at CloudCommerce in November 2011 and in February 2013 was named corporate secretary. In April 2012, Boden was also appointed CFO. In addition, Boden is the managing partner of a private equity company. Prior to joining the CloudCommerce team, Boden managed the franchise accounting and cash application departments of Select Staffing, a nationwide staffing company and was an accountant at KPMG LLP. Boden earned his master of accountancy degree from the University of Denver.
Brad Parscale, Board of Directors
Brad Parscale creates web-marketing strategies and oversees all technical and functional aspects of these strategies. Originally from Kansas, Parscale spent five years in California before moving to San Antonio in 2004 to establish Parscale Media, a successful web-marketing firm. His 2011 partnership with Jill Giles formed Giles-Parscale Inc. In 2016, Parscale was named digital director for the Donald J. Trump presidential campaign.
Zachary Bartlett, VP of Corporate Development and Board of Directors
Zachary Bartlett has been a director of the company since July 2012 and was appointed vice president of Corporate Development in January 2018. Bartlett has also served as vice president of Communications and an independent contractor assisting with project management matters. Prior to joining CloudCommerce, Bartlett was the creative director at Crowbar Studios Inc., a graphic design and web development firm he founded in 2008. From 2004 to 2008, he held the position of art and brand consultant at Demon International, a snowboard accessories company. Bartlett earned his bachelor of fine arts degree in graphic design from Brigham Young University.
CloudCommerce (OTCQB: CLWD), closed Thursday's trading session at $0.003745, up 24.8333%, on 2,731,800 volume with 18 trades. The average volume for the last 3 months is 972,857 and the stock's 52-week low/high is $0.0027/$0.0228.
- CloudCommerce Inc. (CLWD) Discusses Innovation and Strategy in Exclusive Audio Interview
- CloudCommerce Inc.’s (CLWD) Data Analytics Tools Locate Prospects by Personas
- CloudCommerce Inc.’s (CLWD) Market-Behavior Tool Utilizes AI to Bolster Communication Campaigns
Offering an array of investor education products and services, ChineseInvestors.com Inc. (OTCQB: CIIX) provides web-based, real-time financial information in Chinese language character sets. Not only is it a top financial information website for Chinese-speaking investors in the U.S. and China, CIIX is also becoming a major player in the emerging CBD (cannabidiol) market for CBD-based nutrition and health products in China.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.
ChineseInvestors.com (CIIX), closed Thursday's trading session at $0.288, up 10.7692%, on 30,950 volume with 14 trades. The average volume for the last 3 months is 45,876 and the stock's 52-week low/high is $0.25/$1.04999995.
- ChineseInvestors.com Inc. (CIIX) Positioned as First Company to Market CBD Products to Chinese-Speaking Consumers
- CBD Legality Uncertain as Missouri AG Remains Silent
- ChineseInvestors.com Inc. (CIIX) Announces CBD Biotech, Inc.’s Expansion with Products Now Available In Seven New Major Asian Markets
Geyser Brands Inc. (TSX.V: GYSR)
Geyser Brands Inc. (TSX-V: GYSR) ("Geyser Brands" or the "Company) is very pleased to announce a new premium brand line, SToND Naturals ("SToND"). SToND is a line of 100% all-natural self-care products that uses hemp – one of the world's richest sources of polyunsaturated fats that are essential in helping maintain balance in the natural moisture content in the body.
Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.
The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.
Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.
Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.
Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.
Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.
Among the brand formulations in Geyser Brand's portfolio are:
- Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
- Prohibition Cold Brew Mocha designed with water soluble hemp molecules
- Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
- Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control
Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.
CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.
Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.
Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.
Geyser Brands Inc. (TSX.V: GYSR), closed Thursday's trading session at $0.45, off by 8.1633%, on 5,600 volume with 6 trades. The average volume for the last 3 months is 1,412 and the stock's 52-week low/high is $0.409999996/$0.850000023.
- Geyser Brands Launches New Premium Brand Line, SToND Naturals
- Geyser Brands Inc. (TSX.V: GYSR) Targeting Growth with Completion of Solace Management Acquisition, GMP Facility and New Product NPN
- Geyser Brands Inc. (TSX.V: GYSR) Achieves 81% Gross Profit Margin in Q1 2019
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) was highlighted in a publication from CBDWire, examining how the huge supply of hemp on the global market has triggered price wars between producers and prices have started dropping. Estimates indicate that CBD prices have reduced by close to half within the past 12 months. Market watchers attribute the surge in industrial hemp supplies to the zeal with which U.S. farmers took to growing this crop after it was legalized by the Agriculture Improvement Act of 2018 (aka the Farm Bill).
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.
Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hmep-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.
Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.
In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.
Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.
Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.
Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.
Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.
Lexaria Bioscience Corp. (LXRP), closed Thursday's trading session at $0.485, up 15.4762%, on 177,708 volume with 88 trades. The average volume for the last 3 months is 83,907 and the stock's 52-week low/high is $0.399800002/$2.04999995.
- Global CBD Prices Reduce as US Supply Shakes the Market
- Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Powdered Formulation of CBD-Rich Hemp Oil Now Available to US Consumers
- Peer Reviewed Clinical Journal Publishes Lexaria Bioscience's Human CBD Study Results
Marijuana Company of America Inc. (MCOA)
Marijuana Company of America (OTCQB: MCOA) was highlighted in a publication from CBDWire, examining how some calculations put the expected hemp dry matter in the U.S. this year at 180 million pounds, which can yield 4.7 million kilos of CBD isolate. If these figures are accurate, then the supply of CBD in the U.S. could be eight times the existing demand for those products. What this means is that U.S. producers will have to look elsewhere for market, and a drop in the price of CBD products on the European market is testament to the inroads that American companies have made on that continent.
Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.
The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.
The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.
The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.
Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.
Marijuana Company of America Inc. (MCOA), closed Thursday's trading session at $0.15224, up 8.7429%, on 157,749 volume with 130 trades. The average volume for the last 3 months is 245,885 and the stock's 52-week low/high is $0.023/$2.10599994.
- Global CBD Prices Reduce as US Supply Shakes the Market
- 420 with CNW – Benefits of Marijuana to People with Traumatic Brain Injury
- Marijuana Company of America Inc. (MCOAD) Joint Venture Provides Low-Cost, Premium-Cannabis Delivery
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
Plus Products (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis branded products company based in California, this morning announced the start of a national marketing campaign featuring the company’s new 100% hemp CBD product. To view the full press release, visit http://cnw.fm/khu5J.
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed Thursday's trading session at $3.0249, up 4.3069%, on 68,084 volume with 136 trades. The average volume for the last 3 months is 36,791 and the stock's 52-week low/high is $2.51999998/$6.00810003.
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Launches Nationwide Hemp CBD Product Marketing Campaign
- 420 with CNW – A New Study Aims to Find if Marijuana Can be Used to Treat Symptoms of Autism
- Plus Products Advances Strategic Plan with Rebranding, CBD Line Supported by John Legend and Casper Sleep -- CFN Media
MustGrow Biologics Corp. (CSE: MGRO)
The QualityStocks Daily Newsletter would like to spotlight MustGrow Biologics Corp..
MustGrow Biologics Corp. (MGRO-CSE), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides and bio-fertility products for the cannabis industry, is pleased to outline its growing portfolio of natural biologic products.
MustGrow Biologics (CSE: MGRO) is an agricultural biotech company focused on developing and commercializing its patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides.
Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients (http://nnw.fm/Qkz21). For the past 50 years, nematodes have been controlled using chemical nematicides, but the Environmental Protection Agency now restricts or bans many of the chemical?formulations.
MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://nnw.fm/3HGuT), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.
MustGrow’s technology refines mustard seeds to concentrate the plant’s natural organic compounds that form Allyl isothiocyanate (“AITC”), which serves the plant as a natural defense system against pests and diseases. As a result, MustGrow’s novel product offers first-class performance, is 100 percent natural, and its fertilizer product is listed for organic use by the Organic Materials Review Institute (“OMRI”) under specifications set by the USDA’s National Organic Program.
MustGrow’s initial technology was a granular pre-plant soil biofumigant and biofertilizer containing the active ingredient AITC, a proven nematicide, fungicide and fertilizer. The company has completed 110 independent third-party field trials on fruit and vegetable crops. As a biofertilizer, MustGrow’s product is registered with Health Canada and the EPA in all U.S. states as OMRI-certified. It is also registered for use as a biopesticide by the EPA in key fruit and vegetable growing U.S. states (except California) and with Health Canada. MustGrow is finalizing a new liquid delivery platform with increased concentration of the same active ingredient (AITC) that can be applied through drip lines to meet the demands of today’s growers.
Results of tests completed to date show that MustGrow continues to provide innovative solutions with broad based applications within agriculture. Validated field trial results include:
- 100 percent control of root-knot nematodes in strawberry crops as compared to methyl bromide
- 55 percent tomato crop yield increase
- 95 percent control of Pythium root rot in lettuce fields
- 70 percent reduction in Verticillium root severity in cucumbers
- Market Opportunity
MustGrow is also testing the potential application of its technology to the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020. While there are no uniform guidelines for pesticide use in the cannabis industry, state-by-state regulations in the U.S. do exist which has led to instances of pesticide-tainted cannabis showing up in tested products, leading to recalls and threats of lawsuits. Health Canada recently published regulations for mandatory testing for pesticides in cannabis that are now in effect for all growers.?MustGrow’s?potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Cannabis consumers are increasingly demanding organic products free from chemicals and have shown they are willing to pay a premium for high-quality organic cannabis. MustGrow is currently running cannabis soil trials and is seeking Health Canada approval for use of its product on cannabis.?
Global crop protection is a multibillion-dollar market that is expected to surge over the next five years. Sales of nematicides are set to grow by 33 percent to $1.43 billion by 2022, while biopesticides are projected to leap by 94 percent to an estimated?$9.5 billion by 2022. MustGrow is targeting the global nematicide industry with products that include an innovative pre-plant soil treatment. Solutions for the global biopesticide industry include seed treatment technologies, fungicides and nematicides.??
MustGrow’s groundbreaking technologies use novel plant compounds to provide superior crop protection naturally.
President and CEO Corey Giasson is an entrepreneur with more than 20 years in the agriculture, potash, oil and gas, mining and real estate industries.? Mr. Giasson co-founded Rallyemont Energy Inc., a heavy oil company that successfully identified 140 million barrels of recoverable heavy oil, that was sold in 2013 to Husky Energy. He holds an MBA and bachelor’s degree in agricultural economics from the University of Saskatchewan.
Chairman Brad Munro has 20-plus years as a vice president/investments, with a national venture capital firm where he sourced, invested and managed the activity of over 30 companies and invested $150 million. He has served as a director of over 20 public companies and a greater number of private enterprises. Munro is currently director of Secure Energy Services.
COO Colin Betsky is the previous vice president/BioAg at Novozymes, where he was responsible for the company’s BioAg business worldwide. He holds a bachelor’s degree in agriculture from the University of Saskatchewan and has more than 20 years of experience in agricultural chemicals and biologics.
Director Tom Flow is the founder and current president of The Flowr Corporation (TSX.V: FLWR) and Licensed Producer of cannabis in Canada. He founded and built MedReleaf, Canada’s most profitable Licensed Producer which was later acquired by Aurora Cannabis?(TSX: ACB) (NYSE: ACB) for $3.2 billion. Flow is widely recognized for his leadership and expertise in building and operating cannabis cultivation facilities.
Director Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. Under his leadership at Natural Industries, a business focused on biological pest control, the company was awarded five EPA registrations: three biofungicides, a bionematicide, and a bioinsecticide. In November 2012, Kowalski led the strategic sale of Natural Industries to Novozymes BioAg. He is the principal owner of Stronghold Keep Inc., an investment corporation.
CFO Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. He is a Chartered Financial Analyst and a Chartered Professional Accountant.
MustGrow Biologics Corp. (CSE: MGRO), closed Thursday's trading session at $0.30, even for the day, on 215,000 volume. The average volume for the last 3 months is 48,435 and the stock's 52-week low/high is $0.25/$0.699999988.
- MustGrow Outlines Portfolio of Natural Bio-Pesticides and Bio-Fertility Products
- 420 with CNW – Benefits of Marijuana to People with Traumatic Brain Injury
- MustGrow Obtains Exclusive Rights of Streptomyces Bio-Fungicide Product Used to Treat Powdery Mildew in Cannabis Production
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI), parent company of Organigram Inc., today announces the broadcast of its audio interview with NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community. The interview can be heard at http://nnw.fm/4JBwG. Also today, CannabisNewsWire released a report featuring the company which examines the recent news that the company has obtained Health Canada approval for licensing of 17 additional cultivation rooms. The move brings the company’s total target licensed production capacity to 76,000 kilograms per year (http://cnw.fm/9z5aA).
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Thursday's trading session at $3.56, off by 0.558659%, on 2,551,023 volume with 7,844 trades. The average volume for the last 3 months is 1,138,626 and the stock's 52-week low/high is $2.97000002/$8.43999958.
- Organigram Holdings Inc. CEO Discusses Rampant Growth in Exclusive NetworkNewsWire Broadcast
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Obtains Official Licensing, Significantly Increases Production Capacity
- 2020 World Ag Expo to Debut Hemp Pavilion
Spectrum Global Solutions, Inc. (SGSI)
Spectrum Global Solutions (OTCQB: SGSI), a leading single-source provider of next-generation communications network infrastructure and maintenance solutions, this morning announced its recent receipt of $3.3 million in new contract awards across all operating subsidiaries. To view the full press release, visit http://nnw.fm/EJwW7.
Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:
- AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
- ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
- Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.
Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.
Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.
CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.
Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.
Spectrum Global Solutions, Inc. (SGSI), closed Thursday's trading session at $0.0309, up 16.6038%, on 343,241 volume with 32 trades. The average volume for the last 3 months is 169,539 and the stock's 52-week low/high is $0.014999999/$1.49.
- Spectrum Global Solutions, Inc. (SGSI) Secures $3.3 Million in New Contract Awards
- Spectrum Global Solutions Inc. (SGSI) Subsidiary Secures Key Contract with Tier-1 Telecommunications Infrastructure Aggregator
- Spectrum Global Solutions Inc. (SGSI) Secures Key Tier 1 Contract Renewal Amid Ongoing 5G Services Buildup
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1)is ending its FY2019 as one of the few Canadian cannabis businesses building sustainable operations and valuable brands, according to the company’s FY2019 year-end report (http://cnw.fm/vQrj1). The report announced impressive numbers that indicate the company’s stable position in a sector that has been rocked by up-and-down performance throughout the year. Also today, the company was featured in a publication from InvestorBrandNetwork, examining how SPRWF, together with its various divisions and operating assets, is focused on delivering quality products, securing synergistic industry partnerships and employing powerful distribution networks. To view the full article, visit http://cnw.fm/7SAto.
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Thursday's trading session at $0.85235, up 3.8059%, on 547,629 volume with 467 trades. The average volume for the last 3 months is 457,043 and the stock's 52-week low/high is $0.75/$1.7888.
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Posts Record Quarter-End, Year-End Numbers
- Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Providing Premium Brands, Products to Cannabis Industry
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Launches Proprietary Jack Haze Strain
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was featured today in a report by HempWireNews. Farmers in the United States have adopted the cultivation of hemp due to its increased prospects and abandoned mainstream crops such as soybeans which are ensnared in trade conflicts with other countries such as China. Therefore, in search of profitable alternatives, farmers have engaged in the widespread commercial planting of hemp. Also today, CannabisNewsWire released a report on the company detailing how TGODF is increasing its number of institutional holders following the recent clearing of stock overhang. To view the full article, visit http://cnw.fm/E0bOn.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at firstname.lastname@example.org
The Green Organic Dutchman (OTC: TGODF), closed Thursday's trading session at $1.52, up 2.0134%, on 842,715 volume with 658 trades. The average volume for the last 3 months is 709,104 and the stock's 52-week low/high is $1.29999995/$5.2800002.
- Processing Challenges Could Cause Billions in Losses as Hemp Rots on Farms
- Investment Interest in the Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Rises Following BMO Block Trade
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Hosts Industry Analysts at Hamilton and Valleyfield Facilities
VPR Brands, LP (VPRB)
VPR Brands, LP (VPRB) was featured today in the 420 with CNW by CannabisNewsWire. Just a few days after Gov. Tom Wolf (D) announced that he was now in support of legalizing recreational marijuana, a bill has been filed in the state Assembly seeking to create a state-run system through which recreational marijuana can be brought to the state. Under the legislation introduced by Rep. David Delloso (D), adults 21 or older can possess, consume, purchase and even cultivate marijuana through a stores system run by the state through the Liquor Control Commission.
Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.
VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:
- GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit www.cbdgoldline.com.
- HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit www.vapehoneystick.com.
- Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
- Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
- Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
- GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit www.goldlinehemp.com for more information about GoldLine Hemp-only products.
- Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.
CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.
Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.
VPR Brands, LP (VPRB), closed Thursday's trading session at $0.04, even for the day, on 42,999 volume with 4 trades. The average volume for the last 3 months is 145,085 and the stock's 52-week low/high is $0.033799998/$0.119999997.
- 420 with CNW – Marijuana Legalization Bill Introduced in Pennsylvania
- VPR Brands LP (VPRB) CEO is Significant Stockholder in Company, Indicating Confidence in Future Potential
- VPR Brands LP (VPRB) to Debut Premier GOLDLINE CBD Products at NACS 2019
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- B2Digital Inc. (BTDG) Comes Out Fighting for MMA Champions by Building Development League
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) CEO Rings Nasdaq Opening Bell
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) 420 with CNW – Pennsylvania Governor Wolf Announces His Support for Recreational Marijuana Legalization
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Invests Additional US $10 Million in TerrAscend
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Voices Support of SAFE Banking Act
- ChineseInvestors.com (CIIX) CBD Legality Uncertain as Missouri AG Remains Silent
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green (CSE: CVGR) (OTCQB: LRZZF) Achieves Listing, Commences Trading on OTCQB Venture Market
- CloudCommerce (OTCQB: CLWD) Data Analytics Tools Locate Prospects by Personas
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Earth Science Tech, Inc. (ETST) CBD Legality Uncertain as Missouri AG Remains Silent
- Endonovo Therapeutics (OTCQB: ENDV) Appoints Recognized Medical Professional and Business Visionary Dr. William Li as Strategic Advisor to the CEO
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Enters Strategic Agreement with Leading Chinese Infrared Camera Manufacturer
- Genprex, Inc. (NASDAQ: GNPX) Gene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers
- Geyser Brands Inc. (TSX.V: GYSR) Achieves 81% Gross Profit Margin in Q1 2019
- GP Solutions (GWPD) Coverage Initiated for GP Solutions Inc. via NetworkNewsWire
- Grapefruit Boulevard Investments Inc. (IGNG) 420 with CNW – Cannabis Expo in West Michigan Set to Educate Consumers and Businesses about the Marijuana Industry
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) AI Analytics Report Reveals Drivers of the CBD Craze
- Green Hygienics Holdings Inc. (GRYN) 420 with CNW – The Benefits of Marijuana During Breast Cancer Treatment
- Hemptown USA - Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- HTC Extraction Systems (TSX.V: HTC) Achieves Growing Revenues in Q2; Develops CBD FSO Distillate Operation
- INmune Bio, Inc. (NASDAQ: INMB) CEO Discusses Company Achievements in Interview; Director of Neuroscience to Present at World Immunotherapy Congress
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Secures DTC Eligibility, Gets Greenlight to Trade Shares on Domestic Market
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Powdered Formulation of CBD-Rich Hemp Oil Now Available to US Consumers
- Marijuana Company of America Inc. (MCOAD) 420 with CNW – Benefits of Marijuana to People with Traumatic Brain Injury
- MustGrow Biologics Corp (CSE: MGRO) 420 with CNW – Benefits of Marijuana to People with Traumatic Brain Injury
- Neutra Corp. (OTCQB: NTRR) CBD Popularity Growing with Expanded Wellness & Wellbeing Roles; Neutra Corp. Working to Strengthen Market Position
- Nightfood, Inc. (OTCQB: NGTF) Reports Record Quarterly Revenues, Data Indicating Steadily Increasing Same Store Sales
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) 2020 World Ag Expo to Debut Hemp Pavilion
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Ongoing Drill Results Confirm Significant, Near Surface Cobalt and Nickel Mineralization
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Advancing Toward Expansion Plans
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) 420 with CNW – A New Study Aims to Find if Marijuana Can be Used to Treat Symptoms of Autism
- Predictive Oncology Inc. (NASDAQ: POAI) Sells 10 STREAMWAY® Systems to Prominent Teaching Hospital
- Pressure BioSciences Inc. (PBIO) PCT Platform Fills Integral Role for Tumor Analyses in Novel Workflow Presented at IGCS
- Quest Patent Research Corp. (QPRC) Holds Broad Portfolio of Intellectual Property Assets
- Sharing Services Global Corporation (SHRG) Strongly Positioned for Global Growth, Success
- SinglePoint, Inc. (SING) Launching Product, Leading Way in Hemp Space
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces Leading Taxi Technology Distributor Increases Purchase Order to Over $850,000
- Spectrum Global Solutions, Inc. (SGSI) Subsidiary Secures Key Contract with Tier-1 Telecommunications Infrastructure Aggregator
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Announces Expansion With New Manufacturing Facility
- SRAX Inc. (NASDAQ: SRAX) BIGtoken Platform Rewards Consumers for Opting to Release Data
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) CEO to Participate at September 17 Battery Next Summit in Boulder, CO
- Sugarmade, Inc. (SGMD) 420 with CNW – Medical Marijuana Prices in Michigan Rise as Recreational Sales Near
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Launches Proprietary Jack Haze Strain
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Hosts Industry Analysts at Hamilton and Valleyfield Facilities
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Hemp Sports Car Set to Revolutionize the Auto Industry
- Trxade Group Inc. (TRXD) Equipping Community Pharmacies with the Tools Needed to Overcome Their Biggest Challenges
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) 420 with CNW – Four Easy Steps to Getting Your Arizona Medical Marijuana Card in 2019
- VPR Brands, LP (VPRB) CEO is Significant Stockholder in Company, Indicating Confidence in Future Potential
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) London Event Discusses CBD Regulation and Safety
- Willow Biosciences Inc. (CSE: WLLW) London Event Discusses CBD Regulation and Safety
- Xalles Holdings Inc. (XALL) Building Fintech Support Strategy Through Acquisitions, Mentoring
- Youngevity International, Inc. (NASDAQ: YGYI) Announces Dividend Payment Timing for September 2019 Series “D” Cumulative Redeemable Perpetual Preferred Stock
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.